Bromocriptine

Aniket Sidhaye, M.D., Paul Pham, Pharm.D. BCPS
Bromocriptine is a topic covered in the Johns Hopkins Diabetes Guide.

To view the entire topic, please or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Johns Hopkins Guides

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Bromoctriptine-quick release (QR) approved in 2009 for type 2 diabetes mellitus, as an adjunct to diet and exercise
  • Previous indications include: prolactin-secreting adenomas, hyperprolactinemia, acromegaly, Parkinson’s disease

NON-FDA APPROVED USES

  • Neuroleptic malignant syndrome

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: April 9, 2015

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Bromocriptine ID - 547171 A1 - Sidhaye,Aniket,M.D. AU - Pham,Paul,Pharm.D. BCPS Y1 - 2015/04/09/ PB - Johns Hopkins Diabetes Guide UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547171/all/Bromocriptine ER -